Solid Dispersion - a Pragmatic Method to Improve the Bioavailability of Poorly Soluble Drugs

Computational Pharmaceutics: Application of Molecular Modeling in Drug Delivery

Volumn , Issue , 2015, Pages 81-100

  Ke, Peng ^a   Qi, Sheng ^b   Sadowski, Gabriele ^c   Ouyang, Defang ^d  

^a Merck Sharp & Dohme Limited   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c TU DORTMUND UNIVERSITY   (Germany)

^d University of Macau   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BALL MILLING; DISPERSIONS; DRUG DOSAGE; GLASS; GLASS TRANSITION; MELTING; MILLING (MACHINING); POLYMERS; SOLUBILITY; TARGETED DRUG DELIVERY; TEMPERATURE;

POORLY SOLUBLE DRUGS; SOLID DISPERSION; AMORPHOUS DRUGS; BIOAVAILABILITY; MELTING METHOD; MOLECULAR MOBILITY; SOLVENT METHOD;

DRUG DELIVERY; CONTROLLED DRUG DELIVERY;

EID: 84964619483     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118573983.ch5     Document Type: Chapter

References (81)

1. Ke, P., Hasegawa, S., Al-Obaidi, H., Buckton G. Investigation of preparation methods on sur- face/bulk structural relaxation and glass fragility of amorphous solid dispersions. International Journal of Pharmaceutics, 2012. 422(1/2): 170-178.
2. Sekiguchi, K. and N. Obi, Studies on absorption of eutectic mixture. 1. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chemical and Pharmaceutical Bulletin, 1961. 9(11): 866-872.
3. Chiou, W.L. and Riegelman. S., Pharmaceutical applications of solid dispersion systems. Journal of Pharmaceutical Sciences, 1971. 60(9): 1281-1302.
4. Vippagunta, S.R., Z. Wang, S. Hornung, et al., Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. Journal of Pharmaceutical Sciences, 2007. 96(2): 294-304.
5. Janssens, S. and G. Van den Mooter, Review: physical chemistry of solid dispersions. Journal of Pharmacy and Pharmacology, 2009. 61(12): 1571-1586.
6. Vasconcelos, T., B. Sarmento, and P. Costa, Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today, 2007, 12(23/24): 1068-1075.
7. Kanig, J.L., Properties of fused mannitol in compressed tablets. Journal of Pharmaceutical Sciences, 1964. 53: 188-192.
8. Chiou, W.L. and S. Riegelman, Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. Journal of Pharmaceutical Sciences, 1969. 58(12): 1505-1510.
9. Dannenfelser, R.M., H. He, Y. Joshi, et al., Development of clinical dosage forms for a poorly water soluble drug I: application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. Journal of Pharmaceutical Sciences, 2004. 93(5): 1165-1175.
10. Vo, C.L.N., C. Park, and B.J. Lee, Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics, 2013. 85(3, Pt. B): 799-813.
11. Serajuddin, A.T.M., Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. Journal of Pharmaceutical Sciences, 1999. 88(10): 1058-1066.
12. Patterson, J.E., M. B. James, A. H. Forster, et al., Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. International Journal of Pharmaceutics, 2007. 336(1): 22-34.
13. Karanth, H., V.S. Shenoy, and R.R. Murthy, Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report. AAPS PharmSciTech, 2006. 7(4): 8.
14. Claeys, B., Vervaeck, A., Hillewaere, X.K., Possemiers, S., De Beer, T., Remon, J.P., Vervaet, C, Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding. European Journal of Pharmaceutics and Biopharmaceutics. 2014. 90: 44-52.
15. Quinten, T., De Beer, T., Vervaet, C., Remon, J.P, Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets. European Journal of Pharmaceutics and Biopharmaceutics. 2009. 71(1): 145-154.
16. Maniruzzaman, M., Boateng, J.S., Snowden, M.J., Douroumis, D, A review of hot-melt extrusion: process technology to pharmaceutical products. ISRNPharmaceutics. 2012. 436763.
17. Won, D.H., Kim M.S., Lee S., et al., Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. International Journal of Pharmaceutics, 2005. 301(1/2): 199-208.
18. Willart, J.F. and M. Descamps, Solid state amorphization of pharmaceuticals. Molecular Pharmaceutics, 2008. 5(6): 905-920.
19. Gupta, M.K., A. Vanwert, and R.H. Bogner, Formation of physically stable amorphous drugs by milling with neusilin. Journal of Pharmaceutical Sciences, 2003. 92(3): 536-551.
20. Prudic, A., Y. Ji, and G. Sadowski, Thermodynamic phase behavior of API/polymer solid dispersions. Molecular Pharmaceutics, 2014. 11(7): 2294-2304.
21. Leuner, C. and J. Dressman, Improving drug solubility for oral delivery using solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics, 2000. 50(1): 47-60.
22. Ouyang, D., Investigating the molecular structures of solid dispersions by the simulated annealing method. Chemical Physics Letters, 2012. 554: 177-184.
23. Leach, A.R., Molecular Modelling: Principles and Applications. 2nd edn. 2001: Prentice Hall.
24. Langer, M., Holtje M., Urbanetz N.A., et al., Investigations on the predictability of the formation of glassy solid solutions of drugs in sugar alcohols. International Journal of Pharmaceutics, 2003. 252(1/2): 167-179.
25. Yang, H., L. Ze-Sheng, H. Qian, et al., Molecular dynamics simulation studies of binary blend miscibility of poly(3-hydroxybutyrate) and poly(ethylene oxide). Polymer, 2004. 45(2): 453-457.
26. Bogdanova, S., Pajeva, I. Nikolova, P., et al., Interactions of poly(vinylpyrrolidone) with ibuprofen and naproxen: experimental and modeling studies. Pharmaceutical Research, 2005. 22(5): 806-815.
27. Gupta, P. and A.K. Bansal, Molecular interactions in celecoxib-PVP-meglumine amorphous system. Journal of Pharmacy and Pharmacology, 2005. 57(3): 303-310.
28. Gupta, P., Thilagavathi R., Chakraborti A.K., et al., Role of molecular interaction in stability of celecoxib-PVP amorphous systems. Molecular Pharmaceutics, 2005. 2(5): 384-391.
29. Karavas, E., Georgarakis E., Sigalas M.P., et al., Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions. European Journal of Pharmaceutics and Biopharmaceutics, 2007. 66(3): 334-347.
30. Gashi, Z., Censi R., Malaj L., et al., Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: a multi-methodological approach. Journal of Pharmaceutical Sciences, 2009. 98(11): 4216-4228.
31. Oliveira, B.G., Lima, M.C.A., Pitta, I.R., et al., A theoretical study of red-shifting and blue- shifting hydrogen bonds occurring between imidazolidine derivatives and PEG/PVP polymers. Journal of Molecular Modelling, 2010. 16(1): 119-127.
32. Gupta, J., Nunes C., Vyas S., et al., Prediction of solubility parameters and miscibility of pharmaceutical compounds by molecular dynamics simulations. Journal of Physical Chemistry B, 2011. 115(9): 2014-2023.
33. Khan, N. and D.Q.M. Craig, Role of blooming in determining the storage stability of lipid- based dosage forms. Journal of Pharmaceutical Sciences, 2004. 93(12): 2962-2971.
34. Prentis, R.A., Y. Lis, and S.R. Walker, Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). British Journal of Clinical Pharmacology, 1988. 25(3): 387-396.
35. Crowley, M.M., S.K. Battu, S.B. Upadhye, et al., Pharmaceutical applications of hot-melt extrusion: part I. Drug Development and Industrial Pharmacy, 2007. 33(9): 909-926.
36. Repka, M.A., Battu S.K., Upadhye S.B., et al., Pharmaceutical applications of hot-melt extrusion: part II. Drug Development and Industrial Pharmacy, 2007. 33(10): 1043-1057.
37. Paudel, A., Worku Z.A., Meeus J., et al., Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. International Journal of Pharmaceutics, 2012. 453(1): 253-284.
38. Bruce, C.D., Fegely K.A., Rajabi-Siahboomi A.R., et al., The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing EudragitA(r) L10055 or Acryl-EZEA(r). European Journal of Pharmaceutics and Biopharmaceutics, 2010. 75(1): 71-78.
39. Duddu, S.P. and T.D. Sokoloski, Dielectric analysis in the characterization of amorphous pharmaceutical solids. 1. Molecular mobility in poly(vinylpyrrolidone) - Water systems in the glassy state. Journal of Pharmaceutical Sciences, 1995. 84(6): 773-776.
40. Zhou, D., Zhang G.G., Law D., et al., Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin. Molecular Pharmaceutics, 2008. 5(6): 927-936.
41. Tobyn, M., Brown J., Dennis A.B., et al., Amorphous drug-PVP dispersions: application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state. Journal of Pharmaceutical Sciences, 2009. 98(9): 3456-3468.
42. Van den Mooter, G., Wuyts M., Blaton N., et al., Physical stabilisation of amorphous ketocon- azole in solid dispersions with polyvinylpyrrolidone K25. European Journal of Pharmaceutical Sciences, 2000. 12(3): 261-269.
43. Craig, D.Q.M., Barsnes M., Royall P.G., et al., An evaluation of the use of modulated temperature DSC as a means of assessing the relaxation behaviour of amorphous lactose. Pharmaceutical Research, 2000. 17(6): 696-700.
44. Hancock, B.C. and G. Zografi, The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharmaceutical Research, 1994. 11(4): 471-477.
45. Khougaz, K. and S.D. Clas, Crystallization inhibiton in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. Journal of Pharmaceutical Sciences, 2000. 89(10): 1325-1334.
46. Shamblin, S.L., L.S. Taylor, and G. Zografi, Mixing behavior of colyophilized binary systems. Journal of Pharmaceutical Sciences, 1998. 87(6): 694-701.
47. Roos, Y.H., Frozen state transitions in relation to freeze drying. Journal of Thermal Analysis, 1997. 48(3): 535-544.
48. Hancock, B.C., S.L. Shamblin, and G. Zografi, Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharmaceutical Research, 1995. 12(6): 799-806.
49. Hodge, I.M., Effects of annealing and prior history on enthalpy relaxation in glassy polymers. 6. Adam-Gibbs formulation of nonlinearity. Macromolecules, 1987. 20(11): 2897-2908.
50. Aso, Y., S. Yoshioka, and S. Kojima, Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. Journal of Pharmaceutical Sciences, 2004. 93(2): 384-391.
51. Claudy, P., S. Jabrane, and J.M. Letoffe, Annealing of a glycerol glass: enthalpy, fictive temperature and glass transition temperature change with annealing parameters. Thermochimica Acta, 1997. 293(1/2): 1-11.
52. Badrinarayanan, P., W. Zheng, Q. Li, et al., The glass transition temperature versus the fictive temperature. Journal of Non-Crystalline Solids, 2007. 353(26): 2603-2612.
53. Hancock, B.C. and G. Zografi, Characteristics and significance of the amorphous state in pharmaceutical systems. Journal of Pharmaceutical Sciences, 1997. 86(1): 1-12.
54. R. Bohmer, K.L. Ngai, C.A. Angell, D.J. Plazek, Nonexponential relaxations in strong and fragile glass formers. Journal of Chemical Physics, 1993. 99(5): 4201-4209.
55. Bhugra, C.,Shmeis R., Krill S.L., et al., Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition. Pharmaceutical Research, 2006. 23(10): 2277-2290.
56. Hasegawa, S., P. Ke, and G. Buckton, Determination of the structural relaxation at the surface of amorphous solid dispersion using inverse gas chromatography. Journal of Pharmaceutical Sciences, 2009. 98(6): 2133-2139.
57. Qian, F., J. Huang, and M.A. Hussain, Drug-polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development. Journal of Pharmaceutical Sciences, 2010. 99(7): p. 2941-2947.
58. Konno, H. and L.S. Taylor, Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharmaceutical Research, 2008. 25(4): 969-978.
59. Ahlneck, C. and G. Zografi, The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. International Journal of Pharmaceutics, 1990. 62(2/3): 87-95.
60. Wiranidchapong, C., Tucker I.G., Rades T., et al., Miscibility and interactions between 1712- estradiol and EudragitA(r) RS in solid dispersion. Journal of Pharmaceutical Sciences, 2008. 97(11): 4879-4888.
61. Rumondor, A.C.F., Ivanisevic I., Bates S., et al., Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharmaceutical Research, 2009. 26(11): 2523-2534.
62. Telang, C., S. Mujumdar, and M. Mathew, Improved physical stability of amorphous state through acid base interactions. Journal of Pharmaceutical Sciences, 2009. 98(6): 2149-2159.
63. Tang, X.C., M.J. Pikal, and L.S. Taylor, A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers. Pharmaceutical Research, 2002. 19(4): 477-483.
64. Huang, J., R.J. Wigent, and J.B. Schwartz, Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend. Journal of Pharmaceutical Sciences, 2008. 97(1): 251-262.
65. Ng, Y.C., Yang Z., McAuley W.J., et al., Stabilisation of amorphous drugs under high humidity using pharmaceutical thin films. European Journal of Pharmaceutics and Biopharmaceutics, 2013. 84(3): 555-565.
66. Konno, H. and L.S. Taylor, Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. Journal of Pharmaceutical Sciences, 2006. 95(12): 2692-2705.
67. Rumondor, A.C.F. and L.S. Taylor, Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture. Molecular Pharmaceutics, 2010. 7(2): 477-490.
68. Qi, S., J.G. Moffat, and Z. Yang, Early stage phase separation in pharmaceutical solid dispersion thin films under high humidity: improved spatial understanding using probe-based thermal and spectroscopic nanocharacterization methods. Molecular Pharmaceutics, 2013. 10(3): 918-930.
69. Qi, S. and D.Q.M. Craig, Detection of phase separation in hot melt extruded solid dispersion formulations: global vs. localized characterization. American Pharmaceutical Review, 2010. 13(6): 68-74.
70. Zhang, L., M.J. Henson, and S.S. Sekulic, Multivariate data analysis for Raman imaging of a model pharmaceutical tablet. Analytica Chimica Acta, 2005. 545(2): 262-278.
71. Vajna, B., Farkas I., Szabo A., et al., Raman microscopic evaluation of technology dependent structural differences in tablets containing imipramine model drug. Journal of Pharmaceutical and Biomedical Analysis, 2010. 51(1): 30-38.
72. Tajiri, T., Morita S., Sakamoto R., et al., Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging. International Journal of Pharmaceutics, 2010. 395(1/2): 147-153.
73. Weuts, I., Van Dycke F., Voorspoels J., et al., Physicochemical properties of the amorphous drug, cast films, and spray dried powders to predict formulation probability of success for solid dispersions: etravirine. Journal of Pharmaceutical Sciences, 2011. 100(1): 260-274.
74. Zhang, J., Bunker M., Chen X., et al., Nanoscale thermal analysis of pharmaceutical solid dispersions. International Journal of Pharmaceutics, 2009. 380(1/2): 170-173.
75. Qi, S., Gryczke A., Belton P., et al., Characterisation of solid dispersions of paracetamol and EUDRAGITA(r) E prepared by hot-melt extrusion using thermal, microthermal and spectro] scopic analysis. International Journal of Pharmaceutics, 2008. 354(1/2): 158-167.
76. Qi, S., Belton P., Nollenberger K., et al., Characterisation and prediction of phase separation in hot-melt extruded solid dispersions: a thermal, microscopic and NMR relaxometry study. Pharmaceutical Research, 2010. 27(9): 1869-1883.
77. Qi, S., Belton P., Nollenberger K., et al., Compositional analysis of low quantities of phase separation in hot-melt-extruded solid dispersions: a combined atomic force microscopy, photothermal Fourier-transform infrared microspectroscopy, and localised thermal analysis approach. Pharmaceutical Research, 2011. 28(9): 2311-2326.
78. Harding, L., Qi S., Hill G., et al., The development of microthermal analysis and photothermal microspectroscopy as novel approaches to drug-excipient compatibility studies. International Journal of Pharmaceutics, 2008. 354(1/2): 149-157.
79. Dai, X., Moffat J.G., Mayes A.G., et al., Thermal probe based analytical microscopy: thermal analysis and photothermal Fourier-transform infrared microspectroscopy together with thermally assisted nanosampling coupled with capillary electrophoresis. Analytical Chemistry, 2009. 81(16): 6612-6619.
80. Yang, Z., Nollenberger, K., Albers, J., Craig, D., Qi, S., Microstructure of an immiscible polymer blend and its stabilization effect on amorphous solid dispersions. Molecular Pharmaceutics, 2013. 10(7): 2767-2780.
81. Yu, D.G., Zhu, L.-M., White, K., et al., Electrospun nanofiber-based drug delivery systems. Health, 2009. 1(2): 67-75.